News | June 03, 2022
Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
Subscribe To Our Newsletter & Stay Updated
